Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation.
Cairdac has raised $18.8M in total funding. The most recent round was Series A. The last funding was announced in March 2022.
Cairdac's investors include Bpifrance, Mérieux Equity Partners, Supernova Invest, Carvest Crédit Agricole Régions Investissement, Sham.
Cairdac is headquartered in Antony, France.
Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation.
Cairdac is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cairdac — Funding & Investors." VCBacked, March 31, 2022, https://www.vcbacked.co/company/cairdac. Accessed August 18, 2026.
VCBacked. (2022). Cairdac — Funding & Investors. Retrieved August 18, 2026, from https://www.vcbacked.co/company/cairdac
{{cite web |title=Cairdac — Funding & Investors |url=https://www.vcbacked.co/company/cairdac |website=VCBacked |access-date=August 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated